Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
Genetically engineering U937 cells to deliver anti-tumor necrosis factor alpha (anti-TNFa) to the central nervous system (CNS) to alleviate inflammation in Parkinson's disease
FY 2015-16
Summary
Parkinson's disease (PD) is a late-onset neurodegenerative disorder, characterized by motor and cognitive impairments, critically debilitating the elderly (i.e., > 65 years) Canadian population. Widespread neuronal loss impairs function of the central nervous system (CNS). None of the current, available treatments (i.e., drugs, gene therapy, stem-cells) offer a non-invasive, safe, and targeted treatment option. Here, we propose the use of cell-based therapeutics as a viable alternative: genetically programming blood cells to deliver a therapeutic gene to the target neuronal cell population. The blood cells will be programmed with viral particles that redirect them to the brain and transport the therapeutic gene. To test these results, mice models will be used. Our research will pave the way to run future clinical trials in humans introducing a safe and economical therapeutic option for Parkinson's disease. Moreover, this methodology can be adapted to address other neurodegenerative diseases of the like creating an overarching cell-based therapeutic scheme.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
351922
Name
Qudrat Anam
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Genetically engineering U937 cells to deliver anti-tumor necrosis factor alpha (anti-TNFa) to the central nervous system (CNS) to alleviate inflammation in Parkinson's disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cytokines; Inflammation; Lentiviral Infection; Microglia; Monocytes (I.E.; U937)
Abstract
Parkinson's disease (PD) is a late-onset neurodegenerative disorder, characterized by motor and cognitive impairments, critically debilitating the elderly (i.e., > 65 years) Canadian population. Widespread neuronal loss impairs function of the central nervous system (CNS). None of the current, available treatments (i.e., drugs, gene therapy, stem-cells) offer a non-invasive, safe, and targeted treatment option. Here, we propose the use of cell-based therapeutics as a viable alternative: genetically programming blood cells to deliver a therapeutic gene to the target neuronal cell population. The blood cells will be programmed with viral particles that redirect them to the brain and transport the therapeutic gene. To test these results, mice models will be used. Our research will pave the way to run future clinical trials in humans introducing a safe and economical therapeutic option for Parkinson's disease. Moreover, this methodology can be adapted to address other neurodegenerative diseases of the like creating an overarching cell-based therapeutic scheme.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Qudrat, Anam
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~